• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Prevent antibiotic resistances from spreading: Rapid test helps administering the ‘correct’ drug

Bioengineer by Bioengineer
March 13, 2018
in Health
Reading Time: 3 mins read
6
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: S. Döring/ Leibniz-IPHT

Scientists of the Leibniz-Institute of Photonic Technologies (Leibniz-IPHT), Center for Sepsis Control and Care at the University Hospital Jena and Friedrich Schiller University work at a faster and cheaper alternative for hitherto time consuming pathogen diagnostics. Project manager Prof. Ute Neugebauer illustrates the advantages of this new approach: "We combine light-based analytical methods with microfluidic sample processing. With our Lab-on-a-Chip system, thus a miniaturised lab, we are able to clearly identify bacterial strains and their resistances, in less than three hours".

Standard practices for the infectious diagnostics require up to 72 hours to allow for a reliable result. This is due to the fact, that the number of pathogens in a patients sample is too small to conduct tests. Analysis is therefore only possible after time-consuming cultivation. Especially in clinical application during treatments of severe infections e.g. a sepsis time is a crucial factor. Intensive physicians are confronted with an alarming dilemma: "far too often we have to administer broad-spectrum antibiotics 'blindly', because we can neither analyse pathogen nor potential resistances. Therefore, we possibly use a sledge-hammer to crack a nut. A vicious cycle that aides the development of new resistances", explains Prof. Michael Bauer, director of the Clinic of Anesthesiology and Intensive Care at the University Hospital Jena.

The new method out of Jena provides much faster diagnosis as basis for a decision of a reliable therapy. Ute Neugebauer, who works at Leibniz-IPHT and the University Hospital Jena points to tiny electrodes that are fixed on the surface of a stamp-sized chip: "Electric fields secure bacteria in a very small area". Jena's scientists then apply various antibiotics in different concentrations on the trapped bacteria and examine them with Raman spectroscopy. "This means that we irradiate the pathogens with laser light and evaluate the scattered light spectrum", describes Neugebauer the method.

Prof. Jürgen Popp, director of the Leibniz-IPHT and head of the Institute of Physical Chemistry of the Friedrich-Schiller University Jena, explains: "After two hours we can already detect distinct changes in the Raman spectra. Out of these, we can derive wether the strain is resistant or sensible. At the same time we get information on the needed concentration of the antibiotic to constrain bacterial growth. This is an important diagnostic parameter that influences the success of a treatment decidedly", Popp continues. The results of the team of chemists, physicians, and biologists were published in the current edition of the renowned journal Analytical Chemistry, which was released in February 2018.

The combination of fast, light-based diagnostics and a high automation level reduces the time from sampling to result from to date 72 to three and a half hours. "Such a fast procedure could revolutionise diagnostics of infectious diseases", Prof. Bettina Löffler, director of the Institute of Medical Microbiology at the University Hospital Jena, is sure about that. Currently, researchers work at a platform for the application in hospitals. Another, more far reaching, aim is the further development into a catridge-based rapid test system, which will enable general practitioners to identify resistances in a fast and easy way for the first time. Thereby, physicians would hold a powerful tool, from which they could benefit in personalised therapy, this means the administration of a fitting drug.

###

The research was funded by the European Union, the Federal Ministry for Education and Research, the Free State of Thuringia, and the Carl-Zeiss-Foundation.

Media Contact

Dr. Ute Neugebauer
[email protected]
@Leibniz_IPHT

Startseite

Original Source

https://www.leibniz-ipht.de/en/institute/presse/news/detail/ausbreitung-von-antibiotika-resistenzen-eindaemmen-schnelltest-hilft-bei-der-vergabe-des-richtigen.html http://dx.doi.org/10.1021/acs.analchem.7b03800

Share12Tweet7Share2ShareShareShare1

Related Posts

Lymph Node Subtypes Reveal Colorectal Cancer Insights

Lymph Node Subtypes Reveal Colorectal Cancer Insights

August 22, 2025
CrAAVe-seq reveals key neuronal genes in vivo

CrAAVe-seq reveals key neuronal genes in vivo

August 22, 2025

Blocking Spermine Metabolism Boosts Pancreatic Cancer Immunity

August 22, 2025

Vaginal Estrogen Tablets Show Safety Potential for Postmenopausal Stroke Survivors

August 22, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Lymph Node Subtypes Reveal Colorectal Cancer Insights

Boosted Growth in Preterm Infants via Protein-Fortified Milk

Nutrition Education Prevents Malnutrition in Radiotherapy

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.